TG Therapeutics, Inc. (TGTX)
54.91
+1.57
(+2.94%)
USD |
NASDAQ |
Oct 09, 13:36
TG Therapeutics Total Return Level : 53.34 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 53.34 |
| October 07, 2026 | 52.95 |
| October 06, 2026 | 52.19 |
| October 05, 2026 | 53.91 |
| October 02, 2026 | 54.29 |
| October 01, 2026 | 53.62 |
| September 30, 2026 | 55.78 |
| September 29, 2026 | 56.19 |
| September 28, 2026 | 56.19 |
| September 25, 2026 | 57.43 |
| September 24, 2026 | 57.52 |
| September 23, 2026 | 56.00 |
| September 22, 2026 | 58.11 |
| September 21, 2026 | 57.16 |
| September 18, 2026 | 56.87 |
| September 17, 2026 | 56.47 |
| September 16, 2026 | 55.85 |
| September 15, 2026 | 53.04 |
| September 14, 2026 | 54.00 |
| September 11, 2026 | 53.89 |
| September 10, 2026 | 55.39 |
| September 09, 2026 | 54.65 |
| September 08, 2026 | 55.74 |
| September 04, 2026 | 55.98 |
| September 03, 2026 | 56.71 |
| Date | Value |
|---|---|
| September 02, 2026 | 56.90 |
| September 01, 2026 | 56.09 |
| August 31, 2026 | 54.30 |
| August 28, 2026 | 53.93 |
| August 27, 2026 | 55.72 |
| August 26, 2026 | 55.03 |
| August 25, 2026 | 55.42 |
| August 24, 2026 | 56.01 |
| August 21, 2026 | 54.27 |
| August 20, 2026 | 50.56 |
| August 19, 2026 | 51.69 |
| August 18, 2026 | 50.26 |
| August 17, 2026 | 49.28 |
| August 14, 2026 | 48.74 |
| August 13, 2026 | 47.94 |
| August 12, 2026 | 49.50 |
| August 11, 2026 | 49.90 |
| August 10, 2026 | 49.16 |
| August 07, 2026 | 49.76 |
| August 06, 2026 | 49.55 |
| August 05, 2026 | 49.88 |
| August 04, 2026 | 48.74 |
| August 03, 2026 | 46.17 |
| July 31, 2026 | 52.03 |
| July 30, 2026 | 53.53 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Krystal Biotech, Inc. | 327.30 |
| Vertex Pharmaceuticals, Inc. | 503.25 |
| SELLAS Life Sciences Group, Inc. | 11.26 |
| Travere Therapeutics, Inc. | 52.04 |
| Alnylam Pharmaceuticals, Inc. | 224.53 |